by Single use downstream bioprocessing refers to the processing of biomolecules after fermentation, involving purification, filtration and other procedures. The technology utilizes single-use consumables instead of traditional stainless steel-based equipment for downstream operations. Key advantages include reduced capital investment, ease of scalability and prevention of cross-contamination. The biopharma industry has shown increased preference for such disposable systems over conventional counterparts to minimize operational costs for small-scale production runs.
The Single Use Downstream Bioprocessing Market is estimated to be valued at US$ 1.51 Bn in 2024 and is expected to exhibit a CAGR of 15% over the forecast period 2024-2031.
Key Takeaways
Key players operating in the single use downstream bioprocessing are 3M, Agilitech, CPC (Colder Products Company), Cytiva Lifesciences, Pall Corporation and Among Others.
The market provides lucrative opportunities for players in the form of rising number of product approvals and increased outsourcing of bioproduction by large pharma companies. Rapid growth of the biosimilars industry has further augmented demand.
Major players are focusing on capacity expansion through new facility constructions as well as acquisitions. For instance, 3M has expanded its operations through the acquisition of M*Modal’s technology solutions business. Additionally, geographical expansion into emerging Asian markets with growing biotech industries offers significant scope over the coming years.
Market Drivers
One of the key drivers for the single use downstream bioprocessing market growth is the increasing adoption of disposable technologies by small and medium scale manufacturers. The use of single-use systems eliminates the need for expensive facility setup and validation requirements associated with traditional stainless steel based equipment. This offers significant cost savings for companies involved in research and early phase production. Further, it enables quick transition between product pipelines.
PEST Analysis
Political: Changes in healthcare legislations and regulations for pharmaceutical approvals can impact the demand for single use bioprocessing technologies. Countries are working towards streamlining approval processes to make bioprocessing more efficient.
Economic: Higher R&D investments in cell and gene therapies along with vaccine development are expected to drive growth of single use bioprocessing market. Cost benefits of single use systems compared to traditional stainless steel also supports its adoption.
Social: Growing awareness about diseases and importance of timely diagnosis and treatment are increasing the demand for biologics. This puts pressure on biopharmaceutical companies to reduce production timelines using single use technologies.
Technological: Bioprocessing industry is continuously innovating to develop more advanced single use bioreactors, mixers,bags and connectors to enable scalable development and manufacturing of complex biologics. Data analytics further helps optimize processes.
Geographical regions: North America holds the largest share of the market currently due to presence of major biopharma companies and availability of advanced healthcare infrastructure. High adoption of single use technologies for production of monoclonal antibodies and vaccines makes this region an important market.
The Asia Pacific region is expected to see the fastest growth during the forecast period. Improving regulatory environment, increasing biopharma investments and lower production costs are key reasons for the rising demand. Countries like China, India and South Korea are emerging as globally significant locations for bioprocessing. Their focus on expanding local biologics manufacturing capacities indicate strong potential for single use technologies.
What Are The Key Data Covered In This Single Use Downstream Bioprocessing Market Report?
:- Market CAGR throughout the predicted period
:- Comprehensive information on the aspects that will drive the Single Use Downstream Bioprocessing’s growth between 2024 and 2031.
:- Accurate calculation of the size of the Single Use Downstream Bioprocessing and its contribution to the market, with emphasis on the parent market
:- Realistic forecasts of future trends and changes in consumer behaviour
:- Single Use Downstream Bioprocessing Industry Growth in North America, APAC, Europe, South America, the Middle East, and Africa
:- A complete examination of the market’s competitive landscape, as well as extensive information on vendors
:- Detailed examination of the factors that will impede the expansion of Single Use Downstream Bioprocessing vendors
FAQ’s
Q.1 What are the main factors influencing the Single Use Downstream Bioprocessing?
Q.2 Which companies are the major sources in this industry?
Q.3 What are the market’s opportunities, risks, and general structure?
Q.4 Which of the top Single Use Downstream Bioprocessing companies compare in terms of sales, revenue, and prices?
Q.5 Which businesses serve as the Single Use Downstream Bioprocessing’s distributors, traders, and dealers?
Q.6 How are market types and applications and deals, revenue, and value explored?
Q.7 What does a business area’s assessment of agreements, income, and value implicate?
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
About Author - Money Singh
Money Singh is a seasoned content writer with over four years of experience in the market research sector. Her expertise spans various industries, including food and beverages, biotechnology, chemicals and materials, defense and aerospace, consumer goods, etc. LinkedIn Profile
